GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹4,963 Cr | ₹3,342 Cr | ₹1,858 Cr | ₹3,665 Cr | ₹3,101 Cr |
What is the latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹4,963 Cr |
| Mar2025 | ₹3,342 Cr |
| Mar2024 | ₹1,858 Cr |
| Mar2023 | ₹3,665 Cr |
| Mar2022 | ₹3,101 Cr |
How is Sundry Debtors of GLENMARK PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,963 Cr | 48.52 | |
| Mar2025 | ₹3,342 Cr | 79.83 | |
| Mar2024 | ₹1,858 Cr | -49.30 | |
| Mar2023 | ₹3,665 Cr | 18.19 | |
| Mar2022 | ₹3,101 Cr | - | |
Compare Sundry Debtors of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹64,659.1 Cr | 0.4% | -7.5% | 11.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,539.0 Cr | -1.4% | -6.6% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 1.2% | -2.6% | 60% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,251.0 Cr | -2% | -6.1% | 33% | Stock Analytics | |
| CIPLA | ₹105,290.0 Cr | -2.3% | -5.8% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,752.6 Cr | -1.1% | 3.8% | -5.5% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 0.4% |
-7.5% |
11.7% |
| SENSEX | 0.8% |
-4.8% |
-10.5% |
You may also like the below Video Courses